$56.60
0.10 (+0.18%)
Amgen, Inc. (AMGN)
CAPS Rating:
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.